Evidence map›Paper›PMID 29947003›Full record

ArticleAnnals of surgical oncology2018

Correction to: 1 Versus 2-cm Excision Margins for pT2-pT4 Primary Cutaneous Melanoma (MelMarT): A Feasibility Study.

Marc D Moncrieff, David Gyorki, Robyn Saw, Andrew J Spillane, John F Thompson, Howard Peach, Deemesh Oudit, Jenny Geh, Peter Dziewulsk, Ewan Wilson and 14 more

Abstract readPublished Erratum
PubMed Full text at PMC Publisher
In one paragraph

Article in Annals of surgical oncology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

24 authors.

Marc D MoncrieffNorfolk & Norwich University Hospital, Norwich, UK. marc.moncrieff@nnuh.nhs.uk.
David GyorkiPeter MacCallum Cancer Centre, Melbourne, Australia.
Robyn SawMelanoma Institute Australia, Sydney, Australia.
Andrew J SpillaneMelanoma Institute Australia, Sydney, Australia.
John F ThompsonMelanoma Institute Australia, Sydney, Australia.
Howard PeachLeeds Teaching Hospitals, Leeds, UK.
Deemesh OuditChristie NHS Trust, Manchester, UK.
Jenny GehGuy's & St Thomas's NHS Trust, London, UK.
Peter DziewulskSt Andrew's Centre for Burns & Plastic Surgery, Chelmsford, UK.
Ewan WilsonNorth Bristol NHS Trust, Bristol, UK.
Paolo MatteucciHull & East Yorkshire NHS Trust, Hull, UK.
Rowan Pritchard-JonesMersey Centre for Burns & Plastic Surgery, Liverpool, UK.
Roger Olofsson BaggeSahlgrenska University Hospital, Göteborg, Sweden.
Frances C WrightSunnybrook Health Sciences Centre, Toronto, Canada.
Nic CramptonGold Coast Melanoma Clinic, Queensland, Australia.
Oliver CassellOxford University Hospitals NHS Trust, Oxford, UK.
Navid JallaliImperial Hospital NHS Trust, London, UK.
Adam BergerJefferson University Hospitals, Philadelphia, USA.
John KellyThe Alfred Hospital, Melbourne, Australia.
Stephen HamiltonRoyal Free Hospital NHS Trust, London, UK.
Amer DurraniCambridge University Hospitals, Cambridge, UK.
Serigne LoMelanoma Institute Australia, Sydney, Australia.
Elizabeth PatonMelanoma Institute Australia, Sydney, Australia.
Michael A HendersonPeter MacCallum Cancer Centre, Melbourne, Australia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In the original article John F. Thompson was inadvertently omitted as an author. The author list is updated as shown in this correction.

Identifiers

PMID29947003
PMCPMC6829792

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.